It is known that both ATLL and PTCL, NOS with genomic aberrations express CC chemokine receptor (CCR) 4, while PTCL, NOS without genomic aberrations expresses CCR3. This evidence concerns the gene CCR3 and mature T-cell and NK-cell non-Hodgkin lymphoma.